Skip to main content
. 2022 Jan 20;13:20406207211072838. doi: 10.1177/20406207211072838

Table 3.

Characteristics of cGVHD before MSC treatment.

Characteristics of cGVHD cGHVD group (n = 7)
Severity of cGVHD, n (%)
 Moderate 4 (57.1)
 Severe 3 (42.9)
Site of cGVHD, n (%)
 Skin 5 (71.4)
 Liver 5 (71.4)
 Eye 2 (28.6)
 Lung 2 (28.6)
 GI 2 (28.6)
Number of sites, n (%)
 1 1 (14.3)
 ⩾1 6 (85.7)
Total cGVHD treatments before MSC, median (range) 3 (2–5)
Second-line cGVHD treatments before MSC, n (%)
 2 1 (14.3)
 ⩾3 6 (85.7)

cGVHD, chronic graft-versus-host disease; GI, gastrointestinal tract; MSC, mesenchymal stromal cell.